Literature DB >> 8264730

Isolation, characterization and analysis of the expression of the Leishmania ribosomal PO protein genes.

M Soto1, J M Requena, C Alonso.   

Abstract

Two tandemly linked genes are present in the Leishmania infantum genome that code for the acidic ribosomal PO protein. The genes are identical in the coding region, although a striking lack of nucleotide sequence conservation is observed when the boundaries of the coding regions between both genes are compared. The 3' untranslated regions of the two genes are, moreover, different in size. The deduced amino acid sequence of the L. infantum PO protein (LiPO) shows a high degree of sequence conservation, including the highly charged conserved C-terminal domain, with the ribosomal PO proteins of other eukaryotic organisms. Northern blot experiments showed that two different size class transcripts are expressed in the gene cluster and that the steady state level of each of the transcripts in logarithmic phase promastigotes is markedly different. The abundance of both transcripts is down-regulated in parasite cultures on reaching stationary phase. Since it seems that the two Leishmania ribosomal PO genes are expressed in a single polycistronic transcript, it is likely that the different levels of PO mRNAs observed in cultured cells is due to a postranscriptional regulatory mechanism.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8264730     DOI: 10.1016/0166-6851(93)90072-6

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  8 in total

1.  Multicomponent chimeric antigen for serodiagnosis of canine visceral leishmaniasis.

Authors:  M Soto; J M Requena; L Quijada; C Alonso
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

2.  Identification of new antigens in visceral leishmaniasis by expression cloning and immunoblotting with sera of kala-azar patients from Bihar, India.

Authors:  Stephan M Theinert; Rajatava Basu; Michael Forgber; Syamal Roy; Shyam Sundar; Peter Walden
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

3.  The Leishmania infantum acidic ribosomal protein P0 administered as a DNA vaccine confers protective immunity to Leishmania major infection in BALB/c mice.

Authors:  Salvador Iborra; Manuel Soto; Javier Carrión; Ana Nieto; Edgar Fernández; Carlos Alonso; Jose M Requena
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

4.  Antigens shared by Leishmania species and Trypanosoma cruzi: immunological comparison of the acidic ribosomal P0 proteins.

Authors:  Y A Skeiky; D R Benson; M Elwasila; R Badaro; J M Burns; S G Reed
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

5.  During active viscerocutaneous leishmaniasis the anti-P2 humoral response is specifically triggered by the parasite P proteins.

Authors:  M Soto; J M Requena; L Quijada; S O Angel; L C Gomez; F Guzman; M E Patarroyo; C Alonso
Journal:  Clin Exp Immunol       Date:  1995-05       Impact factor: 4.330

6.  Complete assembly of the Leishmania donovani (HU3 strain) genome and transcriptome annotation.

Authors:  Esther Camacho; Sandra González-de la Fuente; Alberto Rastrojo; Ramón Peiró-Pastor; Jose Carlos Solana; Laura Tabera; Francisco Gamarro; Fernando Carrasco-Ramiro; Jose M Requena; Begoña Aguado
Journal:  Sci Rep       Date:  2019-04-16       Impact factor: 4.379

7.  The transcriptome of Leishmania major in the axenic promastigote stage: transcript annotation and relative expression levels by RNA-seq.

Authors:  Alberto Rastrojo; Fernando Carrasco-Ramiro; Diana Martín; Antonio Crespillo; Rosa M Reguera; Begoña Aguado; Jose M Requena
Journal:  BMC Genomics       Date:  2013-04-04       Impact factor: 3.969

8.  Gene Annotation and Transcriptome Delineation on a De Novo Genome Assembly for the Reference Leishmania major Friedlin Strain.

Authors:  Esther Camacho; Sandra González-de la Fuente; Jose C Solana; Alberto Rastrojo; Fernando Carrasco-Ramiro; Jose M Requena; Begoña Aguado
Journal:  Genes (Basel)       Date:  2021-08-29       Impact factor: 4.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.